Go beyond cholesterol. Understand your cardiovascular health.
Your heart health is about more than your cholesterol level.
Swan Science's
Advanced Heart Health Blood Test provides a detailed assessment of 14 cardiovascular biomarkers, including advanced cholesterol measurements, lipoproteins and inflammation-related markers.
Designed for adults who want to take a proactive approach to their long-term health, this specialist blood test offers additional insight into factors associated with cardiovascular disease.
Whether you're establishing a baseline, have a family history of heart disease or want a more detailed understanding of your cholesterol profile, this test provides valuable information to support informed conversations with your healthcare professional.
Why choose an Advanced Heart Health Test?
Traditional cholesterol tests typically measure total cholesterol, HDL, LDL and triglycerides. While these are important, they don't provide the complete picture of cardiovascular risk.
Our Advanced Heart Health Test includes additional biomarkers such as
Apolipoprotein B (ApoB), Lipoprotein(a) and high-sensitivity C-Reactive Protein (hs-CRP).
These measurements may provide useful additional information about cholesterol-carrying particles, inherited cardiovascular risk and inflammation.
The test is particularly relevant for people who want to understand their cardiovascular biomarkers in greater detail.
What does the test measure?
1. Cholesterol and lipid health
- Total Cholesterol: Measures the overall cholesterol concentration in your blood.
- HDL Cholesterol: Often referred to as good cholesterol, HDL participates in cholesterol transport.
- LDL Cholesterol: Often called bad cholesterol, elevated LDL is a major contributor to cardiovascular disease risk.
- Triglycerides: Measures a type of fat circulating in the blood.
- Total Cholesterol/HDL Ratio: Provides additional context when assessing cholesterol levels.
2. Advanced cardiovascular biomarkers
- Apolipoprotein B (ApoB): Measures a protein found on potentially artery-clogging lipoprotein particles. It can provide additional information about cardiovascular risk.
- Apolipoprotein A-I (ApoA-I): The major protein associated with HDL particles.
- ApoB/ApoA-I Ratio: Compares two important apolipoprotein measurements.
- Lipoprotein(a), Lp(a): A largely inherited cardiovascular risk factor that is not measured in a routine cholesterol test.
- Small LDL Cholesterol: Provides additional information about a smaller LDL particle fraction.
- Apolipoprotein C-II: A protein involved in triglyceride metabolism.
- Apolipoprotein C-III: A protein involved in triglyceride-rich lipoprotein metabolism.
- Apolipoprotein E (ApoE): A protein involved in lipid transport and metabolism.
3. Inflammation-related marker
- High-Sensitivity C-Reactive Protein (hs-CRP): Measures low concentrations of an inflammatory marker that may provide additional cardiovascular risk information in appropriate clinical circumstances.
Who might benefit from this test?
This test may be suitable for adults who:
- Want a more detailed understanding of their cholesterol and cardiovascular biomarkers.
- Have a family history of high cholesterol or cardiovascular disease.
- Are interested in proactive health monitoring, particularly in midlife.
- Have previously had cholesterol testing and would like to discuss additional lipid measurements.
- Want to understand their inherited Lipoprotein(a) level.
- Are health-conscious or physically active and want additional insight into cardiovascular risk factors.
What makes this test different from a standard cholesterol test?
A standard cholesterol test provides valuable information about blood lipids.
The Advanced Heart Health Blood Test goes further by including additional measurements such as ApoB, Lp(a), specialised apolipoproteins and hs-CRP.
Some of these biomarkers can provide information not captured by traditional cholesterol results.
Not every additional biomarker is necessary for every individual, and some specialist measurements have limited established use in routine cardiovascular assessment. Results should therefore be interpreted in the context of your personal health history and recognised risk factors.
Simple clinic blood collection
Your test requires a venous blood sample collected by a trained healthcare professional at a participating clinic.
Your sample is then sent to a specialist laboratory for analysis.
The laboratory's published panel specification indicates an approximate
72-hour turnaround from sample receipt, although transport and reporting times may affect when your results become available.
Understand your results and next steps
Your laboratory report provides the results of the included cardiovascular biomarkers.
These measurements can help inform discussions about cholesterol management, cardiovascular risk factors and whether additional medical assessment is appropriate.
For example, an elevated Lp(a) measurement may identify an inherited risk factor that warrants consideration alongside cholesterol, blood pressure, smoking status, diabetes and family history.
The aim is to help you better understand your health and make informed decisions about appropriate next steps.
Take a proactive approach to heart health
Cardiovascular disease can develop over many years, sometimes without obvious symptoms.
Understanding relevant risk factors is one way to support informed preventive healthcare decisions.
Understand your health. Know what to do next.
Important information
This is a cardiovascular biomarker assessment, not a diagnostic test for heart disease, heart attack or stroke.
The results cannot independently determine your overall cardiovascular risk or confirm that your heart is healthy. Clinical cardiovascular risk assessment also considers factors such as age, blood pressure, smoking, diabetes, medical history and family history.
If you have cardiovascular symptoms, seek appropriate medical assessment rather than relying on blood testing alone. New or severe chest pain, particularly with breathlessness, sweating or pain spreading to the arm or jaw, requires urgent medical attention.
Some advanced biomarkers have limited established value in routine screening. Repeat-testing frequency should be based on clinical need rather than automatically repeated every year.
